טוען...
Druggable Targets in the Rho pathway and their promise for therapeutic control of blood pressure
The prevalence of high blood pressure (also known as hypertension) has steadily increased over the last few decades. Known as a silent killer, hypertension increases the risk for cardiovascular disease and can lead to stroke, heart attack, kidney failure and associated sequela. While numerous hypert...
שמור ב:
| הוצא לאור ב: | Pharmacol Ther |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7235948/ https://ncbi.nlm.nih.gov/pubmed/30189292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2018.09.001 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|